CASR and neonatal severe primary hyperparathyroidism: After parathyroidectomy the diagnosis of NSHPT was confirmed by genetic testing that revealed a previously reported (3) homozygous nonsense mutation in CaSR: NM_000388.3: c.679 C>T: p. R227X which predicts a truncated protein that would be non-responsive to calcimimetic therapy.